ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1662

The Association Between Radiologic Progression and Serum Levels of Potential Markers of Bone Formation in Ankylosing Spondylitis Patients

Ali Erhan Ozdemirel1, Firas Doghanji2, Orhan Kucuksahin3, Duygu Tecer4, Sebnem Ataman5, Ayse Peyman Yalcin2 and huseyin tutkak6, 1Rheumatology Department, Dıskapı Yıldırım Beyazıt Training And Research Hospital, Ankara, Turkey, 2Physical Medicine and Rehabilitation, Ankara University Faculty of Medicine, Ankara, Turkey, 3Rheumatology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, 4Physical Medicine and Rehabilitation, Division of Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey, 5Rheumatology Department, Ankara University Faculty of Medicine, Ankara, Turkey, 6ankara university immunology, ankara, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), bone turnover markers and modified stoke ankylosing spondylitis spinal score (MSASSS)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Session Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The association between inflammation and spinal damage in Ankylosing Spondylitis (AS) remains unclear. Tumor necrosis factor-α (TNF- α) plays pivotal role in inflammatory process of AS. However current cytokine inhibitor strategies in AS fail to halt new bone formation. This condition propounds that the structural damage of AS patients might be affected by noninflammatory processes or non-TNF- α inflammatory pathways. The aim of this study is to investigate the effects of some markers with possible contributions to structural damage in AS and their relationship with radiographic progression.

Methods:  The study included 238 AS patients and age and sex-matched 150 healthy controls. All AS patients met Modified New York criteria or ASAS axial spondyloarthritis criteria. When patients applied for their routine follow ups, demographic data (age, gender, disease duration, mediacations), ESR, CRP, and total blood count were recorded. Along with the radiographic evaluation (mSASSS), serum levels of DKK-1, BMP-2, BMP-4, Sclerostin (SOST), IL-17, and IL-23 were analyzed.

Results: DKK, SOST, IL17, and IL23 were significantly higher in AS group while bm2 level was significantly lower among AS patients (p<0.001). (table-1) When the association between biomarker levels and disease activity parameters was investigated, bm2 concentration was significantly higher and bm4 concentration was lower among patients with higher BASDAI scores ( >4) (p:0.046, p:0.033 respectively). No statistically significant difference was found between antiTNF and NSAID groups in terms of marker levels ( p>0.05). Variance analyses showed that none of the factors solely affected the mSASSS. However, if bm2, bm4, and IL 17 levels were greater than median values, the mSASSS was affected by 3.3% (p=0.017). DKK, SOST, bmp2 and IL17 affected mSASSS by 2.6% if they exceeded median values (p=0.029). (table-2). These correlations were significant but weak.

Conclusion: The mechanism of new bone formation in AS seem to be complicated and a consequence of inextricable processes. As a manifestation of this confusion, DKK-1 and SOST, with inhibitory effect on bone formation were found to be higher, and BMP-2, a bone formation marker was found to be lower among AS patients. These results propound the importance of local factors (enthesis sites) and possible disease-specific effects of biomarkers.


Disclosure: A. E. Ozdemirel, None; F. Doghanji, None; O. Kucuksahin, UCB, 8,Pfizer Inc, 8,Abbvie, 8,MSD, 8,Roche Pharmaceuticals, 8; D. Tecer, None; S. Ataman, None; A. P. Yalcin, None; H. tutkak, None.

To cite this abstract in AMA style:

Ozdemirel AE, Doghanji F, Kucuksahin O, Tecer D, Ataman S, Yalcin AP, tutkak H. The Association Between Radiologic Progression and Serum Levels of Potential Markers of Bone Formation in Ankylosing Spondylitis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-association-between-radiologic-progression-and-serum-levels-of-potential-markers-of-bone-formation-in-ankylosing-spondylitis-patients/. Accessed February 2, 2023.
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-radiologic-progression-and-serum-levels-of-potential-markers-of-bone-formation-in-ankylosing-spondylitis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences